首页> 中文期刊> 《中国麻风皮肤病杂志》 >重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗疱疹样脓疱病一例并文献复习

重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗疱疹样脓疱病一例并文献复习

         

摘要

A 26-year-old female presented with widespread erythema and superficial sterile pustules for 2 months and aggravated for 1 week. The patient had a psoriatic history for 13 years and she was at 28 week of pregnancy. Laboratory examination revealed hypoalbuminemia, leukocytosis and neutrophilia. Blood and pus were culture-negative for bacilli. The diagnosis of impetigo herpetiformis was made according to the clinical manifestations and laboratory parameters. The patient was treated with human immunoglobulin 20mg and ceftri-axone 1.0 g, once a day for 2 weeks with poor improvement and the recombinant human tumor necrosis factor-α receptor Ⅱ :IgG Fc fusion protein was used additionally, 25 mg, twice a week for 2 weeks. The treatment was effective and a healthy baby was delivered.%患者,女,26岁.全身泛发性红斑、脓疱2个月,加重伴高热1周.银屑病病史13年,妊娠28周.外周血白细胞及中性粒细胞偏高,血及脓疱细菌培养阴性,根据临床表现及辅助检查可诊断为疱疹样脓疱病.入院后给予人免疫球蛋白20 mg,头孢曲松1.0 g,1次/日,治疗2周效果不佳,加用重组人II型肿瘤坏死因子受体-抗体融合蛋白25 mg,2次/周,2周后好转出院,新生儿健康.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号